Artificial Kidney Market

Market CAGR for artificial kidneys is being driven by the rising cases of kidney-related diseases. The rising number of patients distressed from kidney-related throughout the world and the minimum availability of kidney donors is the factor boosting the demand and growth of the artificial kidney market. 

There is an increase in patients agony from renal failure and chronic kidney cases, contributing to the growth of the artificial kidney market. The R&D for the dialysis process and awareness regarding renal failure disease and changing lifestyles are boosting the market growth.

An artificial kidney is a medical device allowing the assistance of dialysis at any time. In order to improve the process of dialysis, R&D activities are being done continuously. The kidney is not able to perform its functions like filtering and removing blood waste and other fluids at the end-stage of kidney disease. 

Hence they require dialysis treatment. The fluid and metabolic waste can be eliminated by dialysis, but they are unable to compensate for the loss of kidney functions like endocrine function, regulating metabolism, and homeostasis. The artificial kidney function assists the human body in living healthy and safe life; it reduces hospital visits for performing dialysis. 

The rising geriatric population and increase in kidney disorders are increasing the adoption of dialysis. Growth in the development of technologies and innovations in artificial kidney devices and related fields is fueling the market.

An increasing number of kidney diseases are leading to high expenditures on healthcare owing to the high costs of treatment, thus boosting the adoption of the wearable artificial kidney market. The Centers for the Disease Control and Prevention (CDC), in 2019, anticipated that people being affected due to chronic kidney disease were over 30 million; this prevalence is due to the sedentary lifestyle and rising consumption of fast food and packaged food having a high levels of calcium and other minerals. 

The wearable kidney is a portable medical device that allows patients to witness the benefits of dialysis at home while doing their day-to-day work. Thus, improving the life of patients suffering from renal diseases as it improves physiological aspects by minimizing hypertension. It also reduces the retention of sodium and reduces the risk of vascular diseases and stroke; this process costs minimum than the treatment available for renal failure patients.

The increasing investment by the key market players for technological advancements and R&D activities to innovate and develop cost-effective products. Thus, driving the Artificial Kidney market revenue.

The Global Artificial Kidney Market Industry is poised for remarkable growth, with projections indicating a rise from 0.41 USD Billion in 2024 to an astounding 74.2 USD Billion by 2035. This trajectory suggests a compound annual growth rate of 60.41% from 2025 to 2035, reflecting the increasing demand for innovative renal therapies. Factors such as the rising prevalence of kidney diseases, technological advancements, and supportive government policies are likely to contribute to this growth. The market's expansion may also be influenced by the aging population and the shift towards home-based dialysis solutions, creating a dynamic landscape for artificial kidney technologies.

Government initiatives aimed at improving healthcare infrastructure significantly impact the Global Artificial Kidney Market Industry. Various countries are increasing funding for kidney disease research and treatment options, recognizing the burden of renal diseases on public health. These initiatives often include grants for innovative medical technologies and subsidies for patients requiring renal replacement therapies. Such support fosters an environment conducive to the development and adoption of artificial kidneys. As governments prioritize healthcare advancements, the market is likely to benefit from enhanced accessibility and affordability, further driving growth in the coming years.

The increasing incidence of chronic kidney diseases globally drives the Global Artificial Kidney Market Industry. According to health statistics, millions of individuals suffer from various forms of kidney ailments, necessitating advanced treatment options. The demand for artificial kidneys is likely to surge as healthcare systems strive to manage this growing patient population. In 2024, the market is projected to reach 0.41 USD Billion, reflecting the urgent need for innovative renal therapies. As awareness of kidney health expands, the market could see significant growth, potentially reaching 74.2 USD Billion by 2035, indicating a robust trajectory for artificial kidney technologies.

The global demographic shift towards an aging population is a critical driver of the Global Artificial Kidney Market Industry. Older adults are more susceptible to kidney diseases, leading to a higher demand for renal replacement therapies. As the population aged 65 and older expands, healthcare systems face mounting pressure to provide effective treatments. This demographic trend is likely to contribute to the market's growth, as artificial kidneys become essential in managing age-related renal issues. The projected market growth from 0.41 USD Billion in 2024 to 74.2 USD Billion by 2035 reflects the increasing healthcare demand associated with an aging society.

There is a growing preference among patients for home-based dialysis solutions, which significantly influences the Global Artificial Kidney Market Industry. Patients increasingly seek autonomy and convenience in managing their health, leading to a shift towards portable and user-friendly artificial kidney devices. This trend is driven by advancements in technology that enable effective home dialysis, reducing the need for frequent hospital visits. As a result, manufacturers are focusing on developing devices that cater to this demand. The market's evolution in response to patient preferences may contribute to its substantial growth in the coming years.

Innovations in medical technology are reshaping the Global Artificial Kidney Market Industry. Recent advancements in bioengineering and nanotechnology have led to the development of more efficient and biocompatible artificial kidneys. These devices are designed to mimic natural kidney functions more effectively, improving patient outcomes. The integration of artificial intelligence in monitoring and managing renal health further enhances treatment efficacy. As these technologies evolve, they are expected to attract investment and research, potentially propelling the market forward. The anticipated compound annual growth rate of 60.41% from 2025 to 2035 underscores the transformative potential of these advancements.

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Artificial Kidney market, dominates the market due to the increased research and development activities by the research centers for innovating artificial kidneys. The region has a rising number of patients suffering from diseases related to the kidneys. They have easy availability of advanced healthcare facilities.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Artificial Kidney MARKET SHARE BY REGION 2022 (USD Billion) 

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe's Artificial Kidney market accounts for the second-largest market share due to the growing cases of diseases related to kidneys and rapid technological developments in the artificial kidney market. Further, the German Artificial Kidney market held the largest market share, and the UK Artificial Kidney market was the rapid-growing market in the European region.

The Asia-Pacific Artificial Kidney Market is expected to grow at the fastest CAGR from 2024 to 2034. This is due to rising healthcare expenditure and growth in the presence of kidney disease in the region. Moreover, China’s Artificial Kidney market held the largest market share, and the Indian Artificial Kidney market was the rapid-growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to spread their product lines, which will help the Artificial Kidney market grow even more. Market participants are also undertaking a various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. 

To expand and survive in a more competitive and rising market climate, the Artificial Kidney industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Artificial Kidney industry to benefit clients and increase the market sector. In recent years, the Artificial Kidney industry has offered some of the most significant advantages to medicine. 

Major players in the Artificial Kidney market, including Kawasumi Laboratories Inc., Blood Purification Technologies Inc., AWAK Technologies Pte. Ltd, Triomed AB, Asahi Kasei Medical Vo. Ltd, US Kidney Research Corporation, Merit Medical Systems, NIPRO Medical Corporation, Fresenius SE & Co. KGaA, and others are trying to increase market demand by investing in research and development operations.

The American Association of Kidney Patients (AAKP) is the largest and oldest independent organization kidney patient, founded in the year 1969. The programs provided by them inform and inspire patients and their families to understand condition of patient and adjust to their circumstances in their communities. It is commited in improving the quality of life for kidney patients via patient engagement, education, advocacy, and fostering of patient communities. 

In August 2018, they announced some plans to join patients' research efforts for the Kidney Project. This kidney project is an effort for the innovation and development of a free-standing bio-artificial kidney for treating End-Stage Renal Disease (ESRD).

AWAK is a patient-eccentric medical technology company that emphasizes improving the lives of dialysis patients and their caregivers by offering solutions to provide improved outcomes by improving their quality of life. AWAK Technologies has innovated portable dialysis machines using customized sorbet; the integrated infusion system is developed for kidney dialysis treatment, hemodialysis, and peritoneal dialysis.

In December 2019, a highly-populated Singapore-based key player, AWAK Technologies, was included in the development of the artificial kidney market. They invested USD 40 million for the development of their wearable peritoneal dialysis devices that have received breakthrough designation from the FDA.